ICISConnect

Browse by Tags

Time to wake up to climate change

India is known to move slowly. So it is perhaps not surprising to read that most local companies have yet to formulate strategies to face the challenge of climate change. KPMG recently released a report on a study carried out earlier this year to understand if Indian business leaders are aware of the...

Posted to ICIS Blogs (Weblog) by Anonymous on 07-30-2008
Confident CRAMS

There are a few optimistic companies that are betting on growth in the midst of inflation, rising crude oil prices and a worldwide economic slowdown. Some custom research and manufacturing services (CRAMS) players believe that the pressure on costs will result in more outsourcing opportunities . This...

Posted to ICIS Blogs (Weblog) by Anonymous on 07-21-2008
Watch Out!

It is time for the Indian chemical industry to wake up to the threat of increased flow of downstream chemicals from the Middle East. Countries such as Saudi Arabia are aggressively pushing for the development of a petrochemicals industry that goes beyond olefins and polyolefins. State-owned and private...

Posted to ICIS Blogs (Weblog) by Anonymous on 06-19-2008
Sign of things to come?

The big news today is Daiichi Sankyo's acquisition of a controlling stake in Ranbaxy , India's largest pharmaceutical company, for $4.6bn. Analysts have been quick to predict many more such deals which will see international pharma majors entering the generic space. Indian generic players have...

Posted to ICIS Blogs (Weblog) by Anonymous on 06-12-2008
Atul inks polymer additives deal with DSM

Atul has successfully secured a contract manufacturing deal with Stamicarbon and DSM Licensing Centre for phosgene-based polymer performance additives used in polyamides. Atul will manufacture the additives based on guidelines given by Stamicarbon with DSM marketing the product worldwide under its brand...

Posted to ICIS Blogs (Weblog) by Anonymous on 06-03-2008
Phosphorus chems in a pickle

Indian chemical companies relying on China for phosphorus are a worried lot. Supplies from China have been erratic for over a year but the Chinese government's decision to raise export tax for phosphorus from 20% to 120% promises to compound the problem. The revised tax is applicable for exports...

Posted to ICIS Blogs (Weblog) by Anonymous on 05-26-2008
Pharma still keen on M&As

The Indian pharmaceutical sector is keeping the M&A fire burning with six deals concluded last month, up from eight in the January-March period. The list includes Jubilant Organosys' $255m acquisition of US-based DRAXIS Health and the $218m buyout of Dabur Pharma by Fresenius Kabi . Indian companies...

Posted to ICIS Blogs (Weblog) by Anonymous on 05-15-2008
Spotlight on Bhopal

Indian papers and news channels are once again buzzing with reports about Dow Chemical and Bhopal. This time it is about the law ministry's view on whether the company should clean up the Bhopal site. The law ministry's comments on a note to the Prime Minister's office were obtained by activists...

Posted to ICIS Blogs (Weblog) by Anonymous on 05-14-2008
Hikal scores in CRAMS

Hikal is busy consolidating its position in the Indian CRAMs (contract research and manufacturing services) space. It recently secured a long-term contract with Bayer CropScience for supply of active ingredients for crop protection chemicals. And now Hikal plans to invest Rs 2bn (US$50m) in setting up...

Posted to ICIS Blogs (Weblog) by Anonymous on 03-14-2008
R&D: India needs to do more

India is seeing a rapid growth in the outsourced R&D business but the country still trails behind China and much of the developed world in this sector. This was evident in the numbers presented by the science and technology minister to the parliament yesterday. India has 150,000 researchers compared...

Posted to ICIS Blogs (Weblog) by Anonymous on 03-13-2008

Page 1 of 2 (13 items) 1 2 Next >